George Chrysos

488 total citations
11 papers, 151 citations indexed

About

George Chrysos is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, George Chrysos has authored 11 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Emergency Medicine and 3 papers in Virology. Recurrent topics in George Chrysos's work include HIV-related health complications and treatments (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). George Chrysos is often cited by papers focused on HIV-related health complications and treatments (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). George Chrysos collaborates with scholars based in Greece and United Kingdom. George Chrysos's co-authors include J. P. Maskell, J. M. Hardie, Armine Sefton, James D. Williams, Stelios Kokkoris, Gregory Giannoulis, Evangelos Georgiou, Dimitra Paraskeva, Panagiotis Korantzopoulos and Panagiotis Gargalianos and has published in prestigious journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and Atherosclerosis.

In The Last Decade

George Chrysos

11 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George Chrysos Greece	6	63	42	34	31	26	11	151
Guglielmo Marco Migliorino Italy	10	106 1.7×	50 1.2×	34 1.0×	56 1.8×	16 0.6×	20	201
Yasemin Akkoyunlu Türkiye	8	56 0.9×	73 1.7×	26 0.8×	14 0.5×	27 1.0×	38	252
Yoshikazu Mutoh Japan	8	123 2.0×	53 1.3×	61 1.8×	43 1.4×	32 1.2×	11	174
Georgios Adamis Greece	7	35 0.6×	76 1.8×	19 0.6×	23 0.7×	10 0.4×	16	139
Arvind V. Bhore India	5	71 1.1×	38 0.9×	14 0.4×	41 1.3×	10 0.4×	11	112
Alessia Zoncada Italy	8	115 1.8×	52 1.2×	10 0.3×	56 1.8×	11 0.4×	13	169
Agathe Becker France	7	24 0.4×	36 0.9×	10 0.3×	25 0.8×	11 0.4×	14	172
X. Argémi France	8	149 2.4×	109 2.6×	35 1.0×	6 0.2×	34 1.3×	18	230
Aida Borgi Tunisia	6	23 0.4×	29 0.7×	18 0.5×	16 0.5×	16 0.6×	17	109
Jeong Eun Lee South Korea	9	84 1.3×	75 1.8×	15 0.4×	6 0.2×	6 0.2×	31	209

Countries citing papers authored by George Chrysos

Since Specialization

Citations

This map shows the geographic impact of George Chrysos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Chrysos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Chrysos more than expected).

Fields of papers citing papers by George Chrysos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Chrysos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Chrysos. The network helps show where George Chrysos may publish in the future.

Co-authorship network of co-authors of George Chrysos

This figure shows the co-authorship network connecting the top 25 collaborators of George Chrysos. A scholar is included among the top collaborators of George Chrysos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Chrysos. George Chrysos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kyriazopoulou, Evdoxia, George Ν. Dalekos, Symeon Metallidis, et al.. (2024). HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIAL. Shock. 61(3). 395–399. 2 indexed citations

Pantazis, Nikos, Maria Chini, Anastasia Antoniadou, et al.. (2018). The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort. PLoS ONE. 13(9). e0203601–e0203601. 5 indexed citations

Chrysos, George, et al.. (2008). Intracranial haemorrhage possibly related to Tipranavir in an HIV-1 patient with cryptococcal meningitis. Journal of Infection. 57(1). 85–87. 5 indexed citations

Chrysos, George, et al.. (2007). Alopecia induced by lopinavir plus ritonavir therapy in an HIV patient.. PubMed. 6(7). 742–3. 7 indexed citations

Kokkoris, Stelios, et al.. (2006). Neurolisteriosis mimicking herpes simplex encephalitis in an immunocompromized patient. Scandinavian Journal of Infectious Diseases. 38(9). 825–828. 7 indexed citations

Chrysos, George, et al.. (2004). Coxsackievirus infection associated with acute pancreatitis.. PubMed. 5(5). 384–7. 16 indexed citations

Chrysos, George, et al.. (2002). Body composition changes in protease inhibitor‐naive HIV‐infected patients treated with two nucleoside reverse transcriptase inhibitors. HIV Medicine. 3(2). 85–90. 29 indexed citations

Touloumi, Giota, Όλγα Κατσαρού, George Chrysos, et al.. (2001). Virological and Immunological Response to HAART Therapy in a Community-Based Cohort of HIV-1-Positive Individuals. HIV Clinical Trials. 2(1). 6–16. 14 indexed citations

Chrysos, George, et al.. (1999). The effects of antiretroviral treatment with protease inhibitors (PIs) on serum lipids in HIV infected patients. Atherosclerosis. 144. 122–122. 1 indexed citations

10.

Chrysos, George, et al.. (1995). Pharmacokinetic interactions of ceftazidime and frusemide.. PubMed. 7 Suppl 4. 107–10. 2 indexed citations

11.

Williams, James D., et al.. (1992). Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. Journal of Antimicrobial Chemotherapy. 30(1). 27–37. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact